Comparing The Safety And Efficacy Of Sitagliptin Vs Dapagliflozin And The Risk Of Hyperkalaemia Among People With Type 2 Diabetes Mellitus And Kidney Disease . VER 2025, 8 (9s), 230-236. https://doi.org/10.64149/J.Ver.8.9s.230-236.